Response to Timothé Ménard.
Publication
, Journal Article
Movaghar, A; Page, D; Brilliant, M; Mailick, M
Published in: Genet Med
March 2022
Duke Scholars
Published In
Genet Med
DOI
EISSN
1530-0366
Publication Date
March 2022
Volume
24
Issue
3
Start / End Page
752 / 753
Location
United States
Related Subject Headings
- Genetics & Heredity
- 3105 Genetics
- 1103 Clinical Sciences
- 0604 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Movaghar, A., Page, D., Brilliant, M., & Mailick, M. (2022). Response to Timothé Ménard. Genet Med, 24(3), 752–753. https://doi.org/10.1016/j.gim.2021.10.023
Movaghar, Arezoo, David Page, Murray Brilliant, and Marsha Mailick. “Response to Timothé Ménard.” Genet Med 24, no. 3 (March 2022): 752–53. https://doi.org/10.1016/j.gim.2021.10.023.
Movaghar A, Page D, Brilliant M, Mailick M. Response to Timothé Ménard. Genet Med. 2022 Mar;24(3):752–3.
Movaghar, Arezoo, et al. “Response to Timothé Ménard.” Genet Med, vol. 24, no. 3, Mar. 2022, pp. 752–53. Pubmed, doi:10.1016/j.gim.2021.10.023.
Movaghar A, Page D, Brilliant M, Mailick M. Response to Timothé Ménard. Genet Med. 2022 Mar;24(3):752–753.
Published In
Genet Med
DOI
EISSN
1530-0366
Publication Date
March 2022
Volume
24
Issue
3
Start / End Page
752 / 753
Location
United States
Related Subject Headings
- Genetics & Heredity
- 3105 Genetics
- 1103 Clinical Sciences
- 0604 Genetics